Moderna COVID-19 vaccines have been suspended in Japan after the discovery of contaminants. It was reported that the Gunma prefectural government stated on Sunday, Aug. 29, that some foreign substances were found in the coronavirus vaccine made by the American biotech company Moderna.
The vaccine was tested after a series of reports regarding contaminants in the product have emerged in Japan. According to Kyodo News, a blackish foreign matter was detected during the inspections prior to the vaccination schedules. The pollutant was said to be less than 0.5 millimeters in size.
The vials have different lot numbers from the initial three lots that were already suspended last week. The Moderna vaccine lots with the contaminants were found last Thursday and Saturday in Okinawa. The vials were said to have black and pink substances in them.
Unfortunately, around 4,500 people were inoculated with the possibly contaminated Moderna shots. The affected lots were used in the vaccinations for over three days last week in Gunma. The territory is the seventh to report about the foreign substance in the Moderna vaccine after Okinawa, Aichi, Gifu, Saitama, Tokyo, and Ibaraki.
The country’s Health, Labor, and Welfare Ministry said that rubber pieces may have dropped into the vials when the needle syringe was punctured into the rubber to take out content. Other than the foreign matter, there is no issue with the quality of the vaccine.
Now, while some experts say that it is safe to continue with the inoculations using Moderna vaccines as the quality is not affected, an investigation has been launched with regards to the death of two Japanese citizens who received the Moderna jab. They were said to have passed away just days after their vaccination.
CNN News reported that the authorities are investigating if the deaths have links to the contaminated Moderna vaccines. As of this time, there is no conclusion yet, but the experts are continuing their assessment to determine the safety of the shots.
Takeda Pharmaceutical Company said in a statement that was released last Saturday, "Currently, no link has been confirmed between these deaths and the Moderna vaccine, but we believe it is important to carry out a formal probe to investigate the matter further."


U.S. Stock Futures Slip as Year-End Trading Turns Cautious
Asia Manufacturing PMI Rebounds as Exports and Tech Demand Drive Growth into 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
South Korea Inflation Rises to 2.3% in December, Matching Market Expectations
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Oil Prices Stabilize at Start of 2026 as OPEC+ Policy and Geopolitical Risks Shape Market Outlook
Singapore GDP Growth Surges in 2025 but Outlook Remains Cautious Amid Global Trade Risks 



